HLUYY H. Lundbeck A/S Sponsored ADRs

H. Lundbeck A/S engages in the research, development, and market of pharmaceutical products for the treatment of psychiatric and neurological disorders. It operates through the following geographical segments: Europe, the Unites States of America, and International Markets. Its product portfolio targets the following diseases: Alzheimer's, depression, Parkinson's, Schizophrenia, alcohol dependence, anxiety, bipolar disorder, epilepsy, and Huntington's. The company was founded by Hans Lundbeck on August 14, 1915 and is headquartered in Valby, Denmark. This is an ADR of a company whose stock trades outside of the U.S. as the symbol DC:LUN.

This security is traded over-the-counter, or OTC. We don't always have accurate pricing data on OTC stocks.

$22.00    Pink
As of 08/09/2022     OTCMarkets

---

Security Information

---

Category1:  US Equity
Category2:  ADRs
Category3:  Large cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  Denmark
Country of incorporation:  Denmark
IPO date:  05/21/2012
Outstanding shares:  796,592,888
Average volume:  1,925
Market cap:   $17,525,043,536
Current dividend yield:  0.00%
Sedol:      

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%